Cavalry Biosciences
2 known investors
Cavalry Biosciences is a biopharmaceutical company focused on developing medicines that leverage the body's inherent regenerative and repair mechanisms, particularly in areas of age-related disease and tissue regeneration. The company applies translational biology and drug development expertise across multiple therapeutic areas.
BiotechDeep TechLongevityMedical Devices
Founders & leadership
Jv
Jan van Deursen, PhDCo-founder, Advisor
N(
Nathaniel (Ned) David, PhDCo-founder, Chairman
Investors · 2
In the news
- Cavalry Biosciences pursues $75M Series B to test eye and muscle disorder drugsendpoints.news · 2026
- Cavalry Biosciences - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2024
- Team - Mission BioCapitalmissionbiocapital.com · 2021